{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:33:36Z","timestamp":1773268416564,"version":"3.50.1"},"reference-count":30,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2016]]},"DOI":"10.7883\/yoken.jjid.2014.246","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T23:07:25Z","timestamp":1434064045000},"page":"56-59","source":"Crossref","is-referenced-by-count":10,"title":["Adverse Drug Reactions in HIV\/AIDS Patients at a Tertiary Care Hospital in Penang, Malaysia"],"prefix":"10.7883","volume":"69","author":[{"given":"Kashifullah","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer Hayat","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Azhar","family":"Sulaiman","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chow Ting","family":"Soo","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, General Hospital Pulau Pinang"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Akhtar","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. Averting HIV and AIDS 2011. Available at <http:\/\/www.avert.org>. Accessed October, 2015."},{"key":"2","unstructured":"2. World Health Organization (WHO)\/The Joint United Nations Programme on HIV\/AIDS (UNAIDS). Report on Global AIDS Epidemic, Geneva: 2012. Available at <http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf>. Accessed October, 2015."},{"key":"3","unstructured":"3. WHO\/UNAIDS Core Epidimiology Slides: Global Summary of the AIDS Epidemic:2013. Available at <http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2013\/gr2013\/201309_epi_core_en.pdf>. Accessed October, 2015."},{"key":"4","unstructured":"4. WHO 2008. Available at <http:\/\/www.who.int\/en\/>."},{"key":"5","unstructured":"5. WHO. WHO Health Statistics 2008. Available at <http:\/\/www.who.int\/gho\/countries\/mys\/country_profiles\/en\/>. Accessed December, 2015."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Goh E, Tan LC, Chow SK, et al. Use of complementary medicine in systemic lupus erythematosus patients in Malaysia. APLAR J Rheumato. 2003;6:21-5.","DOI":"10.1046\/j.0219-0494.2003.00021.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-60.","DOI":"10.1056\/NEJM199803263381301"},{"key":"8","unstructured":"8. Jensen-Fangel S. The effectiveness of highly active antiretroviral therapy in HIV-infected patients. Dan Med Bull. 2004;51:371-92."},{"key":"9","unstructured":"9. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach: 2010 revision. Geneva: 2010."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Minzi OM, Irunde H, Moshiro C. HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania. Tanzan J Health Res. 2009;11:5-10.","DOI":"10.4314\/thrb.v11i1.43243"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Knobel H, Guelar A, Montero M, et al. Risk of side effects associated with the use of nevirapine in treatment-naïve patients, with respect to gender and CD4 cell count. HIV Med. 2008;9:14-8.","DOI":"10.1111\/j.1468-1293.2008.00513.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Taha TE, Kumwenda N, Kafulafula G, et al. Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth. Ann Trop Paediatr. 2004;24:301-9.","DOI":"10.1179\/027249304225019127"},{"key":"13","unstructured":"13. Vigouroux C, Gharakhanian S, Salhi Y, et al. Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease. Diabetes Metab. 1999;25:383-92."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nuesch R, Srasuebkul P, Ananworanich J, et al. Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand. J Antimicrob Chemother. 2006;58:637-44.","DOI":"10.1093\/jac\/dkl313"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Miller CD, El-Kholi R, Faragon JJ, et al. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy. Pharmacotherapy. 2007;27:1379-86.","DOI":"10.1592\/phco.27.10.1379"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45.","DOI":"10.1038\/clpt.1981.154"},{"key":"17","unstructured":"17. Reddy AVK, Ratan J, Lihite RJ, et al. A study on adverse drug reactions in HIV infected patients at an ART centre of tertiary care hospital in Guwahati, India. Asian J Pharm Clin Res. 2013;6:102-4."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Modayil RR, Harugeri A, Parthasarathi G, et al. Adverse drug reactions to antiretroviral therapy (ART): an experience of sponteneous reporting and intensive monitering from ART centre in India. Pharmacoepidemiol Drug Saf. 2010;19:247-55.","DOI":"10.1002\/pds.1907"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Mehta U, Durrheim DN, Blockman M, et al. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV\/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65:396-406.","DOI":"10.1111\/j.1365-2125.2007.03034.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gholami K, Shalviri G. Factors associated with preventability, predictability, and severity of adverse drug reactions. Ann Pharmacother. 1999;33:236-40.","DOI":"10.1345\/aph.17440"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sharma A, Vora R, Modi M, et al. Adverse effects of antiretroviral treatment. Indian J Dermatol Venereol Leprol. 2008;74:234-7.","DOI":"10.4103\/0378-6323.41368"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Eluwa GI, Badru T, Agu KA, et al. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. BMC Clin Pharmacol. 2012;12:7.","DOI":"10.1186\/1472-6904-12-7"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pádua CM, Cesar C, Bonolo PF, et al. High incidence of adverse reactions to initial antiretroviral therapy in Brazil. Braz J Med Biol Res. 2006;39:495-505.","DOI":"10.1590\/S0100-879X2006000400010"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Keiser O, Fellay J, Opravil M, et al. Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification. Antivir Ther. 2007;12:1157-64.","DOI":"10.1177\/135965350701200808"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Van Griensven J, De Naeyer L, Mushi T, et al. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. Trans R Soc Trop Med Hyg. 2007;101:793-8.","DOI":"10.1016\/j.trstmh.2007.02.020"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wester CW, Okezie OA, Thomas AM, et al. Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. J Acquir Immune Defic Syndr. 2007;46:318-22.","DOI":"10.1097\/QAI.0b013e3181568e3f"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kumarasamy N, Venkatesh KK, Cecelia AJ, et al. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDS. 2008;22:337-44.","DOI":"10.1089\/apc.2007.0093"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Singh H, Dulhani N, Tiwari P, et al. A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh. Indian J Pharmacol. 2009;41:224-6.","DOI":"10.4103\/0253-7613.58512"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Bersoff-Matcha SJ, Miller WC, Aberg JA, et al. Sex differences in nevirapine rash. Clin Infect Dis. 2001;32:124-9.","DOI":"10.1086\/317536"},{"key":"30","unstructured":"30. Divakar B, Mistry SD, Kantharia-Mamtarani ND. The study of adverse drug reactions (ADR'S) in HIV patients taking highly active antiretroviral therapy in ART centre, NCH, Surat, India. Int J Med Pharm Sci. 2012;3:9-18."}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/69\/1\/69_JJID.2014.246\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T19:08:59Z","timestamp":1652382539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/69\/1\/69_JJID.2014.246\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2014.246","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}